These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 8616876)

  • 1. K-ras oncogene activation in atypical alveolar hyperplasias of the human lung.
    Westra WH; Baas IO; Hruban RH; Askin FB; Wilson K; Offerhaus GJ; Slebos RJ
    Cancer Res; 1996 May; 56(9):2224-8. PubMed ID: 8616876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pattern of K-ras mutation in pulmonary adenocarcinoma defines a new pathway of tumour development in the human lung.
    Cooper CA; Carby FA; Bubb VJ; Lamb D; Kerr KM; Wyllie AH
    J Pathol; 1997 Apr; 181(4):401-4. PubMed ID: 9196437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A subset of lung adenocarcinomas and atypical adenomatous hyperplasia-associated foci are genotypically related: an EGFR, HER2, and K-ras mutational analysis.
    Sartori G; Cavazza A; Bertolini F; Longo L; Marchioni A; Costantini M; Barbieri F; Migaldi M; Rossi G
    Am J Clin Pathol; 2008 Feb; 129(2):202-10. PubMed ID: 18208799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
    Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL
    Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. K-ras activation in premalignant and malignant epithelial lesions of the human uterus.
    Enomoto T; Inoue M; Perantoni AO; Buzard GS; Miki H; Tanizawa O; Rice JM
    Cancer Res; 1991 Oct; 51(19):5308-14. PubMed ID: 1913654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 alterations in atypical alveolar hyperplasia of the human lung.
    Slebos RJ; Baas IO; Clement MJ; Offerhaus GJ; Askin FB; Hruban RH; Westra WH
    Hum Pathol; 1998 Aug; 29(8):801-8. PubMed ID: 9712420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations of the epidermal growth factor receptor gene in atypical adenomatous hyperplasia and bronchioloalveolar carcinoma of the lung.
    Yoshida Y; Shibata T; Kokubu A; Tsuta K; Matsuno Y; Kanai Y; Asamura H; Tsuchiya R; Hirohashi S
    Lung Cancer; 2005 Oct; 50(1):1-8. PubMed ID: 15950315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung.
    Slebos RJ; Kibbelaar RE; Dalesio O; Kooistra A; Stam J; Meijer CJ; Wagenaar SS; Vanderschueren RG; van Zandwijk N; Mooi WJ
    N Engl J Med; 1990 Aug; 323(9):561-5. PubMed ID: 2199829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung.
    Rodenhuis S; Slebos RJ; Boot AJ; Evers SG; Mooi WJ; Wagenaar SS; van Bodegom PC; Bos JL
    Cancer Res; 1988 Oct; 48(20):5738-41. PubMed ID: 3048648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of codon 12 K-ras mutations in non-neoplastic mucosa from bronchial carina in patients with lung adenocarcinomas.
    Urban T; Ricci S; Danel C; Antoine M; Kambouchner M; Godard V; Lacave R; Bernaudin JF
    Br J Cancer; 2000 Jan; 82(2):412-7. PubMed ID: 10646897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
    Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
    Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of mammalian target of rapamycin reverses alveolar epithelial neoplasia induced by oncogenic K-ras.
    Wislez M; Spencer ML; Izzo JG; Juroske DM; Balhara K; Cody DD; Price RE; Hittelman WN; Wistuba II; Kurie JM
    Cancer Res; 2005 Apr; 65(8):3226-35. PubMed ID: 15833854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. K-ras mutation is an early event in pancreatic duct carcinogenesis in the Syrian golden hamster.
    Cerny WL; Mangold KA; Scarpelli DG
    Cancer Res; 1992 Aug; 52(16):4507-13. PubMed ID: 1643642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased prevalence of K-ras oncogene mutations in lung adenocarcinoma.
    Mills NE; Fishman CL; Rom WN; Dubin N; Jacobson DR
    Cancer Res; 1995 Apr; 55(7):1444-7. PubMed ID: 7882350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of K-ras oncogene activation in human lung cancer and its possible clinical application].
    Zhang G; Sun Y; Wang M
    Zhonghua Jie He He Hu Xi Za Zhi; 1995 Oct; 18(5):282-4, 317. PubMed ID: 8762479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter hypermethylation of hallmark cancer genes in atypical adenomatous hyperplasia of the lung.
    Licchesi JD; Westra WH; Hooker CM; Herman JG
    Clin Cancer Res; 2008 May; 14(9):2570-8. PubMed ID: 18451218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of mutated K-ras gene in surgically resected non-small cell lung cancer patients.
    Rosell R; Li S; Skacel Z; Mate JL; Maestre J; Canela M; Tolosa E; Armengol P; Barnadas A; Ariza A
    Oncogene; 1993 Sep; 8(9):2407-12. PubMed ID: 8395679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ras oncogene point mutation: an infrequent event in bronchioloalveolar cancer.
    Rusch VW; Reuter VE; Kris MG; Kurie J; Miller WH; Nanus DM; Albino AP; Dmitrovsky E
    J Thorac Cardiovasc Surg; 1992 Nov; 104(5):1465-9. PubMed ID: 1331621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic relationship among atypical adenomatous hyperplasia, bronchioloalveolar carcinoma and adenocarcinoma of the lung.
    Morandi L; Asioli S; Cavazza A; Pession A; Damiani S
    Lung Cancer; 2007 Apr; 56(1):35-42. PubMed ID: 17241687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas.
    Kern JA; Slebos RJ; Top B; Rodenhuis S; Lager D; Robinson RA; Weiner D; Schwartz DA
    J Clin Invest; 1994 Feb; 93(2):516-20. PubMed ID: 7906694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.